Anxiety and Related Sleep Disorders - Bangladesh

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$43.16m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.98%, resulting in a market volume of US$45.31m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$5.90 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Bangladesh is experiencing significant growth and development in recent years.

Customer preferences: Customers in Bangladesh are increasingly seeking solutions to manage anxiety and sleep disorders. This can be attributed to various factors such as increasing work-related stress, lifestyle changes, and a growing awareness of mental health issues. As a result, there is a rising demand for medications and therapies that can help individuals cope with anxiety and improve their sleep quality.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Bangladesh is the growing popularity of natural and alternative remedies. Many consumers are turning to herbal supplements, aromatherapy, and relaxation techniques as a way to manage their anxiety and improve their sleep. This trend is driven by a desire for more holistic and natural approaches to healthcare.Another trend in the market is the increasing availability of online resources and telemedicine services. Patients can now access information about anxiety and sleep disorders, as well as consult with healthcare professionals remotely. This trend has been accelerated by the COVID-19 pandemic, which has led to a greater reliance on digital platforms for healthcare services.

Local special circumstances: Bangladesh is a densely populated country with a high prevalence of mental health issues. The rapid urbanization and modernization of the country have contributed to an increase in stress levels among the population. Additionally, the lack of awareness and social stigma surrounding mental health can make it challenging for individuals to seek help for anxiety and sleep disorders. However, there is a growing recognition of the importance of mental health in the country, which is driving the demand for solutions in the market.

Underlying macroeconomic factors: The economic growth of Bangladesh has had a positive impact on the Anxiety and Related Sleep Disorders market. As the country's middle class expands, there is an increase in disposable income and a greater ability to spend on healthcare products and services. Additionally, the government has been investing in healthcare infrastructure and promoting mental health awareness, which has further fueled the growth of the market.In conclusion, the Anxiety and Related Sleep Disorders market in Bangladesh is experiencing significant growth and development. This can be attributed to customer preferences for natural and alternative remedies, the increasing availability of online resources and telemedicine services, as well as local special circumstances such as high stress levels and a growing recognition of mental health issues. The underlying macroeconomic factors, including economic growth and government investment in healthcare, are also contributing to the market's expansion.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.